Medtronic Plc

NYSE: MDT
$89.68
+$0.37 (+0.4%)
Closing Price on November 5, 2024

MDT Articles

These five dividend-paying stocks have solid growth potential and can deliver solid total return. The companies have very strong and defensible business models and products. So their stocks make...
Wednesday's top analyst upgrades and downgrades included Analog Devices, Apple, Best Buy, Dell Technologies, Dollar Tree, Ford, General Electric, General Motors, HP, Medtronic and Zscaler.
24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports expected in this truncated trading week.
Wednesday's top analyst upgrades and downgrades included Baidu, BigCommerce, Boeing, Ciena, Deere, GoodRx, Kohl's, ONEOK, Tesla and Walmart.
BofA Securities has released its top ideas for the rest of 2021. Here are eight top long ideas and two potential shorts for more aggressive investors.
Thursday's top analyst upgrades and downgrades included Arcutis Biotherapeutics, DraftKings, First Solar, InflaRx, Livent, Medtronic, NextEra Energy Partners, Roku, Snowflake and Tesla.
These five high-conviction medical technology health care ideas from Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well during the fourth...
Wednesday's top analyst upgrades and downgrades included Apple, Cheniere Energy, Envision Solar, Livent, Lyft, Nikola, Nio, Roku, Salesforce.com, Shopify, Uber and Vroom.
Medtronic reported better than expected quarterly results before the markets opened on Tuesday.
24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports expected this week, including Best Buy, Hewlett Packard Enterprise and Salesforce.com.
With the market showing the potential for some sizable rotation, the research team at BofA Securities has added Medtronic to the firm's US 1 List of top stocks to buy. It and three other US 1 health...
Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the risk of rising hospitalizations that go well beyond COVID-19.
The current focus on controlling the COVID-19 pandemic, companies that provide other health care products and services have received less attention from investors and analysts. Here are seven that...
See why UBS feels these 10 stocks in a variety of sectors with solid upside potential could do very well with a Joe Biden victory in November.
One big merger was announced Wednesday when Allstate offered to pay $4 billion in cash for insurer National General. A second merger between two medical device makers has also been rumored.